Concord Biotech Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 273.61 | 341.43 | 288.22 |
| Operating Expense | 173.34 | 203.51 | 179.19 |
| Net Profit | 61.19 | 90.02 | 67.78 |
| Net Profit Margin | 22.36% | 26.37% | 23.52% |
| Earning Per Share | 5.85 | 8.60 | 6.48 |
| EBIDTA | 99.63 | 138.22 | 108.08 |
| Effective Tax Rate | 20.32% | 20.77% | 19.78% |
Particulars
Jun 2026
Revenue273.61
Operating Expense173.34
Net Profit61.19
Net Profit Margin22.36
Earning Per Share5.85
EBIDTA99.63
Effective Tax Rate20.32
